| # | Title | Journal | Year | Citations |
|---|
| 1 | Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies | Molecular Psychiatry | 2022 | 967 |
| 2 | Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder | World Psychiatry | 2015 | 581 |
| 3 | Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk | Biological Psychiatry | 2015 | 516 |
| 4 | Factors Related to Physician Burnout and Its Consequences: A Review | Behavioral Sciences (Basel, Switzerland) | 2018 | 500 |
| 5 | Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study | Schizophrenia Bulletin | 2009 | 368 |
| 6 | Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk | JAMA Psychiatry | 2015 | 284 |
| 7 | Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia | JAMA Psychiatry | 2015 | 277 |
| 8 | North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment | Schizophrenia Research | 2012 | 235 |
| 9 | 20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20) | World Psychiatry | 2020 | 232 |
| 10 | Negative symptoms in individuals at clinical high risk of psychosis | Psychiatry Research | 2012 | 226 |
| 11 | Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study | Biological Psychiatry | 2013 | 221 |
| 12 | Binge eating in the bariatric surgery population: A review of the literature | International Journal of Eating Disorders | 2007 | 218 |
| 13 | Association of Neurocognition With Transition to Psychosis | JAMA Psychiatry | 2016 | 205 |
| 14 | Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project | Schizophrenia Bulletin | 2015 | 195 |
| 15 | Preventive psychiatry: a blueprint for improving the mental health of young people | World Psychiatry | 2021 | 183 |
| 16 | Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia | American Journal of Psychiatry | 2010 | 181 |
| 17 | Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects | World Psychiatry | 2020 | 167 |
| 18 | Association of Antidepressant Use With Adverse Health Outcomes | JAMA Psychiatry | 2019 | 143 |
| 19 | Predicting risky choices from brain activity patterns | Proceedings of the National Academy of Sciences of the United States of America | 2014 | 137 |
| 20 | A large‐scale meta‐analytic atlas of mental health problems prevalence during the COVID‐19 early pandemic | Journal of Medical Virology | 2022 | 134 |
| 21 | Smoking and depression | Medical Clinics of North America | 2004 | 132 |
| 22 | D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial | Lancet Psychiatry,the | 2015 | 128 |
| 23 | Risk and protective factors for mental disorders beyond genetics: an evidence‐based atlas | World Psychiatry | 2021 | 127 |
| 24 | Clinical guideline recommendations for antipsychotic long-acting injections | British Journal of Psychiatry | 2009 | 118 |
| 25 | Tardive dyskinesia risk with first‐ and second‐generation antipsychotics in comparative randomized controlled trials: a meta‐analysis | World Psychiatry | 2018 | 117 |
| 26 | Lithium Treatment of Acute Mania in Adolescents: A Large Open Trial | Journal of the American Academy of Child and Adolescent Psychiatry | 2003 | 115 |
| 27 | Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk | JAMA Psychiatry | 2018 | 114 |
| 28 | A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania | Psychological Medicine | 2015 | 105 |
| 29 | Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia | Journal of Clinical Psychopharmacology | 2010 | 104 |
| 30 | Effect of Zuranolone vs Placebo in Postpartum Depression | JAMA Psychiatry | 2021 | 102 |
| 31 | A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology | Psychotherapy and Psychosomatics | 2020 | 101 |
| 32 | Early traumatic experiences in those at clinical high risk for psychosis | Microbial Biotechnology | 2013 | 95 |
| 33 | Comorbid diagnoses for youth at clinical high risk of psychosis | Schizophrenia Research | 2017 | 95 |
| 34 | Editor's Introduction: The Empirical Status of the Ultra High-Risk (Prodromal) Research Paradigm | Schizophrenia Bulletin | 2007 | 93 |
| 35 | The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms | Schizophrenia Bulletin | 2017 | 84 |
| 36 | Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development | CNS Drugs | 2019 | 82 |
| 37 | Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis | Human Brain Mapping | 2014 | 76 |
| 38 | Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review | World Psychiatry | 2021 | 76 |
| 39 | Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis | Psychological Medicine | 2019 | 74 |
| 40 | A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment | Journal of Clinical Psychiatry | 2011 | 74 |
| 41 | Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study | American Journal of Psychiatry | 2020 | 72 |
| 42 | Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis | Schizophrenia Bulletin | 2015 | 71 |
| 43 | Gender Dysphoria in Adults: An Overview and Primer for Psychiatrists | Transgender Health | 2018 | 68 |
| 44 | Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS) | Schizophrenia Research | 2014 | 66 |
| 45 | Depression and heart disease: What do we know, and where are we headed? | Cleveland Clinic Journal of Medicine | 2009 | 66 |
| 46 | The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: A naturalistic study of the North American Prodrome Longitudinal Sample | Schizophrenia Research | 2009 | 61 |
| 47 | Do Asian Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Overview | Indian Journal of Psychological Medicine | 2020 | 61 |
| 48 | Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis | Social Psychiatry and Psychiatric Epidemiology | 2016 | 60 |
| 49 | Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases | American Journal of Therapeutics | 2018 | 60 |
| 50 | Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania | Bipolar Disorders | 2007 | 59 |
